Nova-Eye Medical Limited (ASX:EYE) has disclosed that director Thomas George Duthy acquired 150,000 ordinary shares on 19 November 2026, with the transaction conducted through the entity CIPA Investments Pty Ltd <CIPA Investments A/C> at a total consideration of $24,000.

Key Points

  • Director Thomas George Duthy acquired 150,000 ordinary shares on 19 November 2026
  • The acquisition was an on-market purchase at a total consideration of $24,000
  • Securities are held indirectly through CIPA Investments Pty Ltd <CIPA Investments A/C>
  • Total indirect holding in ordinary shares increased from 200,000 to 350,000 following the change
  • The trade was not conducted during a closed period

Transaction Details for Director Thomas George Duthy

According to the filing lodged with the ASX, director Thomas George Duthy held 200,000 ordinary shares indirectly prior to the change. On 19 November 2026, an additional 150,000 ordinary shares were acquired via an on-market purchase. The registered holder of the securities is CIPA Investments Pty Ltd <CIPA Investments A/C>, through which Duthy holds an indirect interest. The total consideration paid for the acquired shares was $24,000. No securities were disposed of as part of this transaction.

Post-Transaction Indirect Shareholding Position

Following the on-market purchase, the filing states that Thomas George Duthy's total indirect holding in Nova-Eye Medical ordinary shares stands at 350,000, held through CIPA Investments Pty Ltd <CIPA Investments A/C>. The director's previous notice was dated 10 November 2026. No changes to the director's interests in contracts were disclosed, with Part 2 of the filing recording no applicable contract details.

Closed Period Confirmation

The filing confirms that the securities detailed in the notice were not traded during a closed period in which prior written clearance was required. The disclosure was made pursuant to listing rule 3.19A.2 and as agent for the director under section 205G of the Corporations Act. Nova-Eye Medical Limited holds ABN 15 007 702 927. No further information regarding the nature of the company's operations or additional transaction details was included in the filing.